CheckOrphan
BioEnergy
GreenBio
BioBasel
 
left shadow
bottom shadow
top top
Syngenta receives approval for triple stack corn in Brazil
Monday, February 7, 2011

Syngenta announced today that the National Biosafety Committee (CTNBio) in Brazil has approved its triple corn stack Bt11 x MIR162 x GA21 for cultivation in the country. The triple stack will be available to Brazilian growers for the 2011/2012 season.

"We are very pleased to receive this first approval for any triple stack product in Brazil. It demonstrates our ability to bring innovative technology to market," said Davor Pisk, Chief Operating Officer Seeds. The approval reinforces our portfolio for Brazilian growers and brings greater convenience and increased productivity.

The triple corn stack Bt11 x MIR162 x GA21 combines herbicide tolerance and insect resistance. The MIR162 trait (Agrisure Viptera) offers outstanding control of fall army worm, the main insect threat to corn in Brazil, and of other damaging lepidopteran pests.

Syngenta is one of the world's leading companies with more than 25,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

Source: Syngenta
   
logo